I suspect that it is fair to say that the news is good - but not as overwhelmingly brilliant as was forecast by BIT. Market reaction reflects that to a large extent. BIT seems a little disappointed to be honest - good results but maybe not beyond what was suspected as a neutral set of results.
I am a bit concerned that the COVID results have been withheld - they should require far less analysis and would have less complexity.
COVID is very crowded and maybe those results did not eventuate in a superior treatment.
Results should be good enough to warrant a phase 3 trial for the HIV efforts - will it be good enough to attract a third party though?
In any case, a CR will be required sometime this year and BIT will have some time to seek out a partner - if one is to make itself available.
- Forums
- ASX - By Stock
- BIT
- Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV, page-82
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
|
|||||
Last
4.6¢ |
Change
0.001(2.22%) |
Mkt cap ! $41.50M |
Open | High | Low | Value | Volume |
4.4¢ | 4.7¢ | 4.4¢ | $31.64K | 708.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 4.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 17361 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 259000 | 0.045 |
1 | 200000 | 0.044 |
3 | 415000 | 0.043 |
3 | 322000 | 0.042 |
4 | 287000 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.047 | 200000 | 1 |
0.048 | 308915 | 1 |
0.050 | 21000 | 1 |
0.051 | 96225 | 3 |
0.052 | 1527335 | 2 |
Last trade - 14.10pm 21/06/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online